WS Management’s Teladoc Health TDOC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-100,000
Closed -$2.15M 70
2023
Q4
$2.15M Sell
100,000
-500,000
-83% -$9.22M 0.13% 58
2023
Q3
$11.2M Buy
600,000
+450,000
+300% +$10.5M 0.9% 33
2023
Q2
$3.8M Sell
150,000
-50,000
-25% -$1.26M 0.32% 48
2023
Q1
$5.18M Buy
+200,000
New +$5.35M 0.55% 35
2022
Q4
Sell
-960,000
Closed -$24.3M 85
2022
Q3
$24.3M Buy
+960,000
New +$33.7M 2.21% 11
2022
Q2
Sell
-80,000
Closed -$5.77M 89
2022
Q1
$5.77M Sell
80,000
-77,900
-49% -$5.61M 0.28% 42
2021
Q4
$14.5M Buy
+157,900
New +$18.9M 1.15% 18

Other funds holding TDOC

WS Management's TDOC Position: Q3 2022 in Review

WS Management sold out of Teladoc Health (TDOC) in Q3 2022, closing a stake of 14,500 shares — an estimated $509K sold.

WS Management first reported a position in TDOC in Q2 2022 and held it in 1 quarter. The position peaked at $482K in Q2 2022. 482 funds tracked by Wall St. Rank hold TDOC as of Q3 2022.

  • WS Management reported no remaining Teladoc Health position as of Q3 2022 after selling out during the quarter.
  • WS Management sold 14,500 Teladoc Health shares in Q3 2022, an estimated $509K.
  • WS Management first reported a position in Teladoc Health in Q2 2022 and held it in 1 quarter.
  • WS Management's Teladoc Health position peaked at $482K in Q2 2022.
  • 482 funds tracked by Wall St. Rank held Teladoc Health as of Q3 2022.

Based on WS Management's 13F filing for Q3 2022, filed 14 Nov 2022.